Impetis Biosciences Limited, a active public limited company, was established on 29 May 2017 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999MH2017PLC295474. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.90 Cr and a paid-up capital of ₹3.73 Cr.
It upholds a compliant status. Employing 2 professional, Its leadership includes Abhishek Jain (Director), Kanwar Rameshwar Singh Jamwal (Director), Tarun Dayal Bhojwani (Director). Past directors included Anish Vetteth Raghunandan, Kasim A Mookhtiar, Abhishek Jain. Its latest AGM occurred on 24 June 2025, with the balance sheet filed on 31 March 2025. It is based at 6Th Floor, Wing E, Times Square, Marol, Andheri-Kurla Road, Gamdevi, Andheri-East, Mumbai, Maharashtra, 400059.
U74999MH2017PLC295474
295474
29 May 2017
₹4.90 Cr
₹3.73 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Impetis Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Jain | Director | 04 Mar 2024 | Current |
| Kanwar Rameshwar Singh Jamwal | Director | 29 May 2017 | Current |
| Tarun Dayal Bhojwani | Director | 16 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 26 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Jun 2024 | Past |
| Pramod Abcsdd | Director | 31 Jan 2025 | Past |
| Pramod Abcsdd | Additional Director | 23 Jun 2025 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Impetis Biosciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2031.1% increase. The company also saw a substantial improvement in profitability, with a 465.68% increase in profit. The company's net worth Soared by an impressive increase of 26.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Impetis Biosciences had a promoter holding of 78.84% and a public holding of 21.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Impetis Biosciences has a workforce of 2 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Impetis Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impetis Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Impetis Biosciences Limited last Annual general meeting of members was held on 24 Jun 2025 as per latest MCA records. was documented.
Impetis Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Tarun Dayal Bhojwani was appointed as a Director was appointed as a Director on 16 Jan 2025 & has been associated with this company since 11 months 27 days . was recorded as a recent event.
Abhishek Jain was appointed as a Director was appointed as a Director on 04 Mar 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Kanwar Rameshwar Singh Jamwal was appointed as a Director was appointed as a Director on 29 May 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
Progress on Impetis Biosciences Limited was registered on 29 May 2017 with Roc Mumbai & aged 8 years 7 months as per MCA records. was documented.
The CIN of Impetis Biosciences Limited is U74999MH2017PLC295474.
Impetis Biosciences Limited is headquartered at 6Th Floor, Wing E, Times Square, Marol, Andheri-Kurla Road, Gamdevi, Andheri-East, Mumbai, Maharashtra, 400059.
Impetis Biosciences Limited was incorporated on 29 May 2017.
The current directors of Impetis Biosciences Limited are
The primary industry of Impetis Biosciences Limited is Professional, Scientific And Technical.
Impetis Biosciences Limited is unlisted.
The authorized capital of Impetis Biosciences Limited is ₹4.90 Cr, and the paid-up capital is ₹3.73 Cr.
The compliance status of Impetis Biosciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX